Document:

Exhibit 4.5

 

SECOND AMENDMENT TO THE ALLERGAN,
INC. RETIREMENT 401(k) PLAN

(Amended and Restated as of October 1, 2017)

 

WHEREAS,
Allergan, Inc. (the “Company”) maintains the Allergan, Inc. Retirement 401(k) Plan (Amended and Restated
as of October 1, 2017), as amended (the “Plan”);

 

WHEREAS,
Section 10.1 of the Plan authorizes the Company, by action of the Board of Directors of the Company, the Company’s
officers, or the Allergan Benefits Oversight Committee (the “Oversight Committee”), to make amendments to the Plan;
and

 

WHEREAS,
the Company wishes to amend the Plan, effective January 1, 2018, to allow Plan participants who, not in connection with
an asset sale or stock sale, have become employees of an independent third party immediately following their termination of employment
with the Company, but perform the same services for the Company at the same location they performed such services immediately prior
to such termination of employment (known as “rebadging”) to be eligible to receive Company matching contributions and
profit sharing contributions for the year in which their termination of employment occurs, even if they do not meet the last day
requirement set forth in the Plan.

 

NOW
THEREFORE, BE IT RESOLVED, that the Plan is amended as follows effective January 1, 2018:

 

		1.	Section 5.3(b) shall be amended, effective as of January 1, 2018, to read as follows:

 

		(b)	For Plan Years beginning on or after January 1, 2015, the Company shall contribute and allocate basic Matching Contributions
on a Plan Year basis which, when added to Matching Contribution Forfeitures available after application of Section 6.3 is equal
to one hundred percent (100%) of each Participant’s Matched Deposits for the Plan Year. The Board of Directors (or its delegate,
provided that such change is within the scope of authority of the delegate) may authorize and direct that basic Matching Contributions
(expressed as a percentage of Participants’ Matched Deposits as set forth above) be changed from time to time from a minimum
of zero percent (0%) to a maximum of 100%. In addition, effective for Plan Years beginning on or after January 1, 2016, the Board
of Directors (or its delegate, provided that such change is within the scope of authority of the delegate) may authorize and direct
that basic Matching Contributions (expressed as a percentage of Participants’ Compensation) be changed from time to time
from a minimum of zero percent (0%) to such maximum percentage that when expressed as a percentage of Participants’ Compensation
does not exceed eight percent (8%) of Participants’ Compensation, in aggregate, for any Plan Year. In order to be eligible
to receive a basic Matching Contribution for a Plan Year, the Participant must be employed on the last business day of the Plan
Year or have had a Severance during the Plan Year:

 

		(i)	by reason of the Participant’s Disability or death;

 

    A-1

     

    

 

		(ii)	that is a “Termination Due to a Change of Control,” a “Termination Due to Workforce Restructuring,”
or an “Involuntary Termination without Cause,” within the meaning of the Allergan, Inc. Severance Pay Plan and Summary
Plan Description (the “Severance Plan”) but excluding a discharge from employment with the Company for unsatisfactory
performance that is determined at the sole discretion of the Company to be considered an “Involuntary Termination without
Cause” under the Severance Plan; or

 

		(iii)	(A)	       for the Plan Year beginning on January 1, 2015, on or after the Participant has reached age 55;

 

		(B)	for Plan Years beginning on or after January 1, 2016 but prior to January 1, 2018, on or after the Participant has either (1)
reached age 55 and completed 10 years of Credited Service, or (2) completed 30 years of Credited Service; or

 

		(C)	for Plan Years beginning on or after January 1, 2018, on or after the Participant has either (1) reached age 55 and completed
5 years of Credited Service, (2) completed 30 years of Credited Service, or (3) reached his or her Normal Retirement Age; or

 

		(iv)	for Plan Years beginning on or after January 1, 2018, due to employment by an independent third party immediately following
a Severance, such Severance is unconnected with an asset sale or stock sale by the Company, and such person is performing the same
services for the Company at the same location he or she performed such services immediately prior to such Severance.

 

The basic Matching Contributions
contributed on behalf of Participants who satisfy these requirements shall be allocated to the Matching Contributions Account of
such Participants as of the last day of each Plan Year and shall be paid to the Trust at such times as determined by the Sponsor.”

 

		2.	Section 5.5(c)(i)(C) shall be amended to read as follows:

 

		“(C)	(1)	       for the Plan Year beginning on January 1, 2015, on or after the Participant has reached age 55;

 

		(2)	for Plan Years beginning on or after January 1, 2016 but prior to January 1, 2018, on or after the Participant has either
                                                             (a) reached age 55 and completed 10 years of Credited Service, or (b) completed 30 years of Credited Service;

 

		(3)	for Plan Years beginning on or after January 1, 2018, on or after the Participant has either (1) reached age 55 and completed
5 years of Credited Service, (2) completed 30 years of Credited Service, or (3) reached his or her Normal Retirement Age; or

 

    A-2

    

    

 

		(4)	for Plan Years beginning on or after January 1, 2018, due to employment by an independent third party immediately following
a Severance, such Severance is unconnected with an asset sale or stock sale by the Company, and such person is performing the same
services for the Company at the same location he or she performed such services immediately prior to such Severance.”

 

IN
WITNESS WHEREOF, the Vice President, Compensation & Benefits of Allergan plc hereby causes this Amendment to the
Allergan, Inc. Retirement 401(k) Plan (Amended and Restated as of October 1, 2017), to be adopted as of the date set forth below.

 

	Date:      May 22, 2018	By:	 /s/ Eric Stern
	 	Eric Stern
	 	Its: Vice President, Compensation & Benefits

 

    A-3Exhibit 4.6

 

THIRD AMENDMENT TO THE ALLERGAN,
INC. RETIREMENT 401(k) PLAN

(Amended and Restated as of October 1, 2017)

 

WHEREAS,
Allergan, Inc. (the “Company”) maintains the Allergan, Inc. Retirement 401(k) Plan (Amended and Restated
October 1, 2017), as amended (the “Plan”);

 

WHEREAS,
Section 10.1 of the Plan authorizes the Company, by action of the Board of Directors of the Company, the Company’s
officers, the Allergan Benefits Oversight Committee, or to the extent plan sponsor authority has been so delegated, to the Employee
Benefits Committee, to make amendments to the Plan;

 

WHEREAS,
the Company has determined that it is in its best interest to amend the Plan to permit participation in the Plan by
employees who are considered non-resident aliens for purposes of the Internal Revenue Code of 1986, as amended, but have U.S. source
earned income from a participating employer in the Plan, such as F-l visa holders; and

 

WHEREAS,
the Vice President, Rewards of Allergan plc has the authority to amend the Plan (on behalf of the Company).

 

NOW
THEREFORE, BE IT RESOLVED, that the Plan is amended as follows:

 

1. Section 2.22(a) shall be amended, effective as of May 1,
2019, to read as follows:

 

“(a)
any non-resident alien who receives no earned income (within the meaning of Code Section 911(d)(2)) from an Employer that constitutes
income from sources within the United States, as defined in Code Section 861(a)(3).”

 

IN
WITNESS WHEREOF, the Vice President, Rewards of Allergan plc hereby causes this Third Amendment to the Allergan, Inc.
Retirement 401(k) Plan (Amended and Restated as of October 1, 2017), to be adopted as of the date set forth below.

 

	Date:      April 30, 2019	By:	/s/ Eric Stern
	 	Eric Stern
	 	Its: Vice President, RewardsExhibit 4.7

 

FOURTH AMENDMENT TO THE ALLERGAN, INC.
RETIREMENT 401(k) PLAN

(Amended and Restated as of October 1,
2017)

 

WHEREAS,
Allergan, Inc. (the “Company”) maintains the Allergan, Inc. Retirement 401(k) Plan, as amended (the “Plan”);

 

WHEREAS,
Section 10.1 of the Plan authorizes the Company, by action of the Board of Directors of the Company, the Company’s officers,
the Allergan Benefits Oversight Committee, or to the extent plan sponsor authority has been so delegated, to the Allergan Employee
Benefits Committee, to make amendments to the Plan;

 

WHEREAS,
prior to May 1, 2019, the Plan excluded from participation employees who were considered non-resident aliens for purposes of the
Internal Revenue Code of 1986, as amended (the “Code”);

 

WHEREAS,
effective as of May 1, 2019, the Plan was amended to permit participation in the Plan by employees who are considered
non-resident aliens for purposes of the Code, but have U.S. source earned income from a participating employer in the Plan;

 

WHEREAS,
Section 5.5(d) of the Plan provides that profit sharing contributions may be made for a Plan year that are allocable solely to
participants who are not Highly Compensated Employees (as such term is defined in the Plan, hereinafter referred to as “HCEs”)
or a specified group of participants who are not HCEs, provided the Company first documents, in writing, the specific identity
of each participant who will receive a profit sharing contribution and the specific amount allocated to each participant, such
list to be incorporated by reference into the Plan;

 

WHEREAS,
the Company wishes to amend the Plan to provide a profit sharing contribution for the 2019 Plan year under Section 5.5(d) of the
Plan on behalf of three employees who (i) were non-resident aliens in 2018 for purposes of the Code, but had U.S. source earned
income from a participating employer in the Plan; and (ii) are not HCEs for the 2019 plan year;

 

WHEREAS,
the Company believes it is advisable to provide the three employees with a profit sharing contribution for the 2019 Plan year under
Section 5.5(d) of the Plan equal to twelve percent (12%) of their eligible compensation under the Plan for the 2018 plan year,
which is the matching contributions such employees would have been credited with under the Plan had they contributed the maximum
matched deposits under the Plan for the 2018 plan year; and

 

WHEREAS,
the Vice President, Rewards of Allergan plc has the authority to amend the Plan (on behalf of the Company) to reflect the above
profit sharing contribution under Section 5.5(d) of the Plan.

 

    

    

    

 

NOW
THEREFORE, BE IT RESOLVED, that the Plan is amended as follows:

 

Section 5.5(d)
shall be amended, effective as of January 1, 2019, by adding the following paragraph to the end thereof:

 

Notwithstanding Section
5.5(b) and the requirements contained in Section 5.5(c) to be employed on the last day of the Plan year or have a Severance during
the Plan Year for certain reasons (i.e., Sections 5.5(c)(i)(A) – (C)), the following employees listed below shall
be credited with Profit Sharing Contributions for the 2019 plan year in the amount listed below, subject to the conditions of Sections
5.5(d)(ii) and (iii):

 

 

	First Name	 	Last Name	 	Date of Hire	 	 	2018 Eligible

 Compensation	 	 	Special Profit

 Sharing

 Contribution for

 2019 Plan Year	 
	Xin	 	Wang	 	 	3/12/2018	 	 	$	55,192.36	 	 	$	6,623.08	 
	Chan	 	Thunuguntla	 	 	8/27/2018	 	 	$	34,326.91	 	 	$	4,119.23	 
	Pauline	 	Fontaine	 	 	12/17/2018	 	 	$	2,442.31	 	 	$	293.08	 

 

IN
WITNESS WHEREOF, the Vice President, Rewards of Allergan plc hereby causes this Fourth Amendment to the Allergan, Inc.
Retirement 401(k) Plan, to be adopted as of the date set forth below.

 

	Date:     October 14, 2019	By:	/s/ Eric Stern
	 	Eric Stern
	 	Its: Vice President, Rewards

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00310-of-00352.parquet"}]]